Cleared Traditional

LIQUISPEX(TM) LIQUID B2M CONTROL LEVEL 1 AND 2

K946048 · Clinical Controls, Inc. · Immunology
Feb 1995
Decision
60d
Days
Class 2
Risk

About This 510(k) Submission

K946048 is an FDA 510(k) clearance for the LIQUISPEX(TM) LIQUID B2M CONTROL LEVEL 1 AND 2, a System, Test, Beta-2-microglobulin Immunological (Class II — Special Controls, product code JZG), submitted by Clinical Controls, Inc. (Grover Beach, US). The FDA issued a Cleared decision on February 10, 1995, 60 days after receiving the submission on December 12, 1994. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5630.

Submission Details

510(k) Number K946048 FDA.gov
FDA Decision Cleared SESE
Date Received December 12, 1994
Decision Date February 10, 1995
Days to Decision 60 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement

Device Classification

Product Code JZG — System, Test, Beta-2-microglobulin Immunological
Device Class Class II — Special Controls
CFR Regulation 21 CFR 866.5630

Similar Devices — JZG System, Test, Beta-2-microglobulin Immunological

All 52
Beta-2-Microglobulin
K161297 · Beckman Coulter Ireland, Inc. · Jun 2016
HUMAN BETA-2 MICROGLOBULIN URINE KIT FOR USE ON THE SPAPLUS
K122066 · The Binding Site Group , Ltd. · Aug 2012
ADVIA CHEMISTRY REAGENTS, AND ADVIA CHEMISTRY B2-MICROGLOBULIN CALIBRATOR
K110874 · Siemens Healthcare Diagnostics, Inc. · Jan 2012
HUMAN BETA-2 MICROGLOBULIN KIT
K083289 · The Binding Site, Ltd. · May 2009
DIMENSION VISTA BETA 2 MICROGLOBULIN, DIMENSION VISTA PROTEIN 1 CALIBRATOR, DIMENSION VISTA PROTEIN 1 CONTROL M
K083463 · Siemens Healthcare Diagnostics · Mar 2009
QUANTIA BETA-2 MICROGLOBULIN, MODEL: 302822307
K072078 · Biokit, S.A. · Dec 2007